Skip to main content

Table 1 Characteristics of the study group

From: Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis

 Active LN (n = 16)Stable LN (n = 10)AAV (n = 6)IgAN (n = 9)MCD/FSGS (MCD, n = 4; FSGS, n = 1)HC (n = 8)
Age (years)31 (23–45)53 (31.75–61.25)52 (45.5–59.5)45 (35.5–57)53 (40.5–62)49.5 (40.5–55.5)
Female, n (%)15 (93.75)10 (100)4 (66.67)8 (88.89)3 (60)6 (75)
WBC count,  × 103/mL4.43 (3.32–6.54)4.30 (3.67–4.89)9.98 (6.89–15.37)8.1 (7.36–8.35)8.02 (6.28–10.01)5.44 (4.56–7.77)
CRP, mg/L0.15 (0.07–1.15)0.05 (0.03–0.16)2.21 (0.38–10.35)0.03 (0.01–0.15)0.04 (0.02–0.05)0.02 (0.01–0.05)
Serum BUN, mg/dL14.5 (12–18.75)15.5 (12.25–22.25)31 (21.75–58.75)17 (14.5–27)14 (11.5–23.5)15 (11–16)
UPCR, mg/mg2.93 (0.90–5.87)0.21 (0.09–0.36)2.16 (1.233–2.97)1.6 (0.90–4.62)9.55 (3.99–16.88)0.05 (0.04–0.11)
Serum anti-dsDNA, IU/ml512 (267.9–849.8)6.7 (2–155.9)N/AN/AN/AN/A
C3, mg/dL44.5 (39.5–59.75)69.5 (47.75–84.75)106.5 (93.75–112.3)99 (85–124)N/AN/A
C4, mg/dL8 (5.5–16)10.5 (4.5–21)25 (12.5–30.25)28 (20.5–32.5)N/AN/A
  1. The data are presented as the median and interquartile range (IQR) or as number (percentage)
  2. Abbreviations: LN lupus nephritis, AAV ANCA-associated vasculitis, IgAN IgA nephropathy, MCD minimal change disease, FSGS focal segmental glomerulosclerosis, HC healthy control, WBC white blood cell, CRP C-reactive protein, BUN blood urea nitrogen, UPCR urine protein to creatinine ratio, dsDNA double-stranded DNA, C3 complement component 3, C4 complement component 4